版本:
中国

BRIEF-Argentum Pharmaceuticals succeeds in starting patent cancellation trial against Janssen's Zytiga

Sept 19 Argentum Pharmaceuticals:

* Argentum pharmaceuticals says succeeds in starting patent cancellation trial against janssen's zytiga

* Challenges claims 120 of Janssen's U.S. Patent no. 8,822,438, which Orange Book states will expire in 2027

* Final decision on patentability in inter partes review is due within 1 year Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐